Henry Schein, Inc. (HSIC) Receives $84.93 Average Price Target from Brokerages
Shares of Henry Schein, Inc. (NASDAQ:HSIC) have received an average rating of “Hold” from the twenty ratings firms that are presently covering the company, MarketBeat Ratings reports. Four investment analysts have rated the stock with a sell recommendation, eight have issued a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $84.00.
HSIC has been the topic of several research analyst reports. BidaskClub raised Henry Schein from a “buy” rating to a “strong-buy” rating in a report on Thursday, November 1st. Barrington Research raised their target price on Henry Schein from $92.00 to $96.00 and gave the stock an “outperform” rating in a report on Thursday, November 8th. Morgan Stanley raised their target price on Henry Schein from $65.00 to $66.00 and gave the stock an “underweight” rating in a report on Tuesday, October 9th. Goldman Sachs Group initiated coverage on Henry Schein in a report on Saturday, October 20th. They issued a “hold” rating and a $78.00 target price on the stock. Finally, Piper Jaffray Companies reaffirmed an “overweight” rating and issued a $96.00 target price on shares of Henry Schein in a report on Thursday, November 29th.
In other Henry Schein news, insider David Mckinley sold 8,321 shares of the stock in a transaction on Friday, November 30th. The stock was sold at an average price of $88.77, for a total value of $738,655.17. Following the completion of the sale, the insider now owns 68,012 shares in the company, valued at approximately $6,037,425.24. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP Michael S. Ettinger sold 7,425 shares of the stock in a transaction on Monday, December 10th. The stock was sold at an average price of $84.36, for a total value of $626,373.00. Following the completion of the sale, the senior vice president now owns 72,143 shares of the company’s stock, valued at approximately $6,085,983.48. The disclosure for this sale can be found here. Insiders sold a total of 105,856 shares of company stock valued at $9,222,275 in the last quarter. 1.15% of the stock is currently owned by company insiders.
Shares of NASDAQ HSIC traded up $0.28 during midday trading on Friday, hitting $79.76. 1,520,300 shares of the stock traded hands, compared to its average volume of 1,932,050. The stock has a market capitalization of $11.64 billion, a price-to-earnings ratio of 22.16, a PEG ratio of 2.40 and a beta of 0.96. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.30 and a quick ratio of 0.70. Henry Schein has a one year low of $62.56 and a one year high of $91.35.
Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, November 6th. The company reported $1.03 earnings per share for the quarter, beating the consensus estimate of $1.01 by $0.02. The firm had revenue of $3.28 billion for the quarter, compared to analysts’ expectations of $3.37 billion. Henry Schein had a return on equity of 20.40% and a net margin of 3.00%. The company’s revenue was up 3.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.87 EPS. Equities research analysts anticipate that Henry Schein will post 4.12 EPS for the current year.
Henry Schein announced that its Board of Directors has initiated a share buyback program on Thursday, December 13th that allows the company to repurchase $400.00 million in shares. This repurchase authorization allows the company to buy up to 3.1% of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s board believes its stock is undervalued.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Read More: What is a Leveraged Buyout (LBO)?
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.